Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synthelabo's devices sales growth estimated at 7%:

This article was originally published in Clinica

Executive Summary

Sales at Synthelabo's pacemakers and catheters divisions are estimated to grow 7% over the next five years, concludes a report by US analysts Morgan Stanley. They expect "no dramatic developments" in Ela Medical's pacemaker and ECG business over the next few years. Porges' catheter and urology products division reported sales of Fr 173 million ($36 million) in 1994, while Ela Medical posted Fr 489 million revenues for the year. Medical devices represented around 8% of the company's revenues in 1994.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT092653

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel